Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy.
Eisenhofer G, Kurlbaum M, Peitzsch M, Constantinescu G, Remde H, Schulze M, Kaden D, Müller LM, Fuss CT, Kunz S, Kołodziejczyk-Kruk S, Gruber S, Prejbisz A, Beuschlein F, Williams TA, Reincke M, Lenders JWM, Bidlingmaier M. Eisenhofer G, et al. Among authors: muller lm. J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2027-e2036. doi: 10.1210/clinem/dgab924. J Clin Endocrinol Metab. 2022. PMID: 34963138 Free PMC article.
Moderate dietary salt restriction improves blood pressure and mental well-being in patients with primary aldosteronism: The salt CONNtrol trial.
Schneider H, Sarkis AL, Sturm L, Britz V, Lechner A, Potzel AL, Müller LM, Heinrich DA, Künzel H, Nowotny HF, Seiter TM, Kunz S, Bidlingmaier M, Reincke M, Adolf C. Schneider H, et al. Among authors: muller lm. J Intern Med. 2023 Jul;294(1):47-57. doi: 10.1111/joim.13618. Epub 2023 Mar 22. J Intern Med. 2023. PMID: 36945842 Clinical Trial.
The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects.
Spyroglou A, Handgriff L, Müller L, Schwarzlmüller P, Parasiliti-Caprino M, Fuss CT, Remde H, Hirsch A, O'Toole SM, Thuzar M, Petramala L, Letizia C, Deflorenne E, Amar L, Vrckovnik R, Kocjan T, Zhang CD, Li D, Singh S, Katabami T, Yoneda T, Murakami M, Wada N, Inagaki N, Quinkler M, Ghigo E, Maccario M, Stowasser M, Drake WM, Fassnacht M, Bancos I, Reincke M, Naruse M, Beuschlein F. Spyroglou A, et al. Eur J Endocrinol. 2022 Jul 21;187(3):361-372. doi: 10.1530/EJE-22-0040. Print 2022 Sep 1. Eur J Endocrinol. 2022. PMID: 35895721
Screening for Primary Aldosteronism by Mass Spectrometry Versus Immunoassay Measurements of Aldosterone: A Prospective Within-Patient Study.
Fuld S, Constantinescu G, Pamporaki C, Peitzsch M, Schulze M, Yang J, Müller L, Prejbisz A, Januszewicz A, Remde H, Kürzinger L, Dischinger U, Ernst M, Gruber S, Reincke M, Beuschlein F, Lenders JWM, Eisenhofer G. Fuld S, et al. J Appl Lab Med. 2024 Mar 27:jfae017. doi: 10.1093/jalm/jfae017. Online ahead of print. J Appl Lab Med. 2024. PMID: 38532521
Glucocorticoid receptor polymorphism BclI with increased glucocorticoid sensitivity has a positive influence on quality of life in endogenous Cushing's syndrome in remission.
Feldkamp L, Müller L, Deutschbein T, Detomas M, Hahner S, Strasburger CJ, Künzel H, Oßwald A, Braun L, Rubinstein G, Reincke M, Quinkler M, Kienitz T. Feldkamp L, et al. Eur J Endocrinol. 2023 Apr 5;188(4):366-374. doi: 10.1093/ejendo/lvad043. Eur J Endocrinol. 2023. PMID: 36995896
77 results